Stephen C. Schmechel

University of Minnesota — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

27h-index3.2kcitations106works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Fibroblast Growth Factor Research(16), Nerve injury and regeneration(15), Proteoglycans and glycosaminoglycans research(12), Virus-based gene therapy research(10), PI3K/AKT/mTOR signaling in cancer(8)

Publications106 total

Topical Lung Treatment of All-cause ARDS With Instilled T3: Physiologic Basis and Phase I/IIA Trial Results
American Journal of Respiratory and Critical Care Medicine·2025
Supplementary Table and Figure Legends from Canonical Wnt/β-catenin Signaling Drives Human Schwann Cell Transformation, Progression, and Tumor Maintenance
2023Open Access
Supplementary Figure 1 from Canonical Wnt/β-catenin Signaling Drives Human Schwann Cell Transformation, Progression, and Tumor Maintenance
2023Open Access
Supplementary Figure 2 from Canonical Wnt/β-catenin Signaling Drives Human Schwann Cell Transformation, Progression, and Tumor Maintenance
2023Open Access
Supplementary Table and Figure Legends from Canonical Wnt/β-catenin Signaling Drives Human Schwann Cell Transformation, Progression, and Tumor Maintenance
2023Open Access
Data from Canonical Wnt/β-catenin Signaling Drives Human Schwann Cell Transformation, Progression, and Tumor Maintenance
2023Open Access
Supplementary Figure 4 from Canonical Wnt/β-catenin Signaling Drives Human Schwann Cell Transformation, Progression, and Tumor Maintenance
2023Open Access
Supplementary Table 1 from Canonical Wnt/β-catenin Signaling Drives Human Schwann Cell Transformation, Progression, and Tumor Maintenance
2023Open Access
Supplementary Materials from Safe and Effective Sarcoma Therapy through Bispecific Targeting of EGFR and uPAR
2023Open Access
Supplementary Figure 1 from Canonical Wnt/β-catenin Signaling Drives Human Schwann Cell Transformation, Progression, and Tumor Maintenance
2023Open Access
Supplementary Figure 4 from Canonical Wnt/β-catenin Signaling Drives Human Schwann Cell Transformation, Progression, and Tumor Maintenance
2023Open Access
Supplementary Materials from Safe and Effective Sarcoma Therapy through Bispecific Targeting of EGFR and uPAR
2023Open Access
Supplementary Figure 2 from Canonical Wnt/β-catenin Signaling Drives Human Schwann Cell Transformation, Progression, and Tumor Maintenance
2023Open Access
Supplementary Table 2 from Canonical Wnt/β-catenin Signaling Drives Human Schwann Cell Transformation, Progression, and Tumor Maintenance
2023Open Access
Supplementary Table 2 from Canonical Wnt/β-catenin Signaling Drives Human Schwann Cell Transformation, Progression, and Tumor Maintenance
2023Open Access
Data from Safe and Effective Sarcoma Therapy through Bispecific Targeting of EGFR and uPAR
2023Open Access
Data from Canonical Wnt/β-catenin Signaling Drives Human Schwann Cell Transformation, Progression, and Tumor Maintenance
2023Open Access
Supplementary Figure 3 from Canonical Wnt/β-catenin Signaling Drives Human Schwann Cell Transformation, Progression, and Tumor Maintenance
2023Open Access
Data from Safe and Effective Sarcoma Therapy through Bispecific Targeting of EGFR and uPAR
2023Open Access
Supplementary Figure 3 from Canonical Wnt/β-catenin Signaling Drives Human Schwann Cell Transformation, Progression, and Tumor Maintenance
2023Open Access
page 1 of 6Next →

Frequent Co-authors

Anthony E. Rizzardi(15), Jonathan C. Henriksen(10), Colleen L. Forster(8), Stefan E. Pambuccian(8), Joseph S. Koopmeiners(8), Gregory J. Metzger(7), Rachel I. Vogel(5), Leslie A. Schiff(5), David A. Largaespada(4), Eric P. Rahrmann(3), Branden S. Moriarity(3), Aaron L. Sarver(3), James B. McCarthy(3), Christopher A. Warlick(3), Nikolaus K. Rosener(3), J. Carlos Manivel(3), Sibel Blau(3), Colin C. Pritchard(3), Michael O. Dorschner(3), Elisabeth Mahen(3)